In this study, a prime BCG-boost DNA strategy can induce CD8+ T-cell differentiation as well as CD4+ T cell; we suppose that this vaccination strategy may obtain success against TB in humans and gene Rv1769 may be an excellent vaccine candidate. The gene discussed is CD8A; the disease is tuberculosis.